Concepedia

Publication | Closed Access

29LBA Entrectinib (RXDX-101), an oral pan-Trk, ROS1, and ALK inhibitor in patients with advanced solid tumors harboring gene rearrangements

DOI

14

Citations

0

References

2015

Year

Salvatore Siena, Alexander Drilon, I. Ou, Anna F. Farago, Munjal Patel, T.M. Bauer, David S. Hong, Stephen V. Liu, J. Lee, Roopal Patel,
European Journal of Cancer

No additional data available for this publication yet. Check back later!